75
Participants
Start Date
June 30, 2005
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2008
picoplatin
Mt. Sinai Medical Center, New York
Consultants in Medical Oncology & Hematology, Drexel Hill
South Carolina Oncology Associates, PA, Columbia
Georgia Cancer Specialists, Tucker
Central Georgia Hematology Oncology Associates, Macon
Oncology Hematology Group of South Florida, Miami
H. Lee Moffitt Cancer Center, Tampa
The West Clinic, Memphis
Markey Cancer Center, University of Kentucky, Lexington
Medical Center of Vincennes, Vincennes
Hematology Oncology Centers of the Northern Rockies, Billings
The Center for Cancer Care & Research, St Louis
University of Kansas Medical Center, Kansas City
Genesis Cancer Center, Hot Springs
Southwest Regional Cancer Center, Austin
V.A. Sierra Nevada Health Care, Reno
Comprehensive Cancer Center, Palm Springs
Providence Portland Medical Center, Portland
Study Site, Los Angeles
Ufa
Stepanovskoye, Krasnogorskiy District
Petrozavodsk
Engel's
Kazan'
Izhevsk
Cherepovets
Astrakhan
Barnaul
Chelyabinsk
Kaliningrad
Krasnodar
Moscow
Nizhny Novgorod
Omsk
Orenburg
Pyatigorsk
Rostov-on-Don
Saint Petersburg
Samara
Stavropol
Ulyanovsk
Voronezh
Yaroslavl
Yekaterinburg
Eastern Connecticut Hematology/Oncology, Norwich
Augusta Oncology Associates, Augusta
Rush Medical College, Chicago
The Ochsner Clinic, New Orleans
Louisiana State University Health Science Center, Shreveport
University of Missouri / Ellis Fischel Cancer Center, Columbia
Dartmouth-Hitchcock Medical Center Hematology/Oncology, Lebanon
Southeastern Medical Oncology Center, Goldsboro
Vanderbilt University Medical Center, Nashville
Tom Baker Cancer Center, Calgary
Princess Margaret Hospital, Toronto
Lead Sponsor
Poniard Pharmaceuticals
INDUSTRY